SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001035704-99-000292
Filing Date
1999-06-09
Accepted
1999-06-09 00:00:00
Documents
1
Period of Report
1999-07-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT DEF 14A 83459
  Complete submission text file 0001035704-99-000292.txt   85052
Mailing Address 370 17TH STREET SUITE 5200 DENVER CO 802025638
Business Address 370 17TH STREET SUITE 5200 DENVER CO 80202-5638 3032799375
GOLDEN PHARMACEUTICALS INC (Filer) CIK: 0000312651 (see all company filings)

IRS No.: 840645174 | State of Incorp.: CO | Fiscal Year End: 0831
Type: DEF 14A | Act: 34 | File No.: 000-09065 | Film No.: 99642956
SIC: 2835 In Vitro & In Vivo Diagnostic Substances